Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-06-01

AUTHORS

P Jackson, K Ow, G Yardley, W Delprado, D I Quinn, J-L Yang, P J Russell

ABSTRACT

Recent data have proposed that transcription of the KAI1 metastasis suppressor gene is directly mediated by p53 and that loss of KAI1 expression in advanced prostate cancer is simply due to loss of p53 function after mutation. To investigate this possibility, we have examined KAI1 mRNA (by in situ hybridisation) and p53 protein expression (by immunohistochemistry) as an indicator of wildtype or mutant p53, in a series of 77 paraffin-embedded prostate tissue samples, including post-mortem normal prostates (2), benign prostatic hyperplasia (10), localised cancer (grades 4–6, 25; grades 7–9, 21) and prostate-derived bony metastases (19). Overall, we confirmed that expression of KAI1 mRNA decreased from normal tissue, through localised cancer to bony metastases (P=0.055, tending to significance), while levels of p53 staining significantly increased with cancer progression (P=0.046). These were consistent with the possibility that loss of p53 function might be responsible for loss of KAI1 mRNA. However, by close examination of KAI1 and p53 in adjacent tissue sections, we found no correlation between decreased levels of KAI1 mRNA and overexpression of p53 protein (P=0.497). In addition, high levels of KAI1 mRNA could be identified in samples irrespective of p53 staining. Our data suggest that mutation of p53 is independent of the loss of KAI1 mRNA, and do not support a role for p53 in regulating the expression of KAI1. More... »

PAGES

174-181

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.pcan.4500634

DOI

http://dx.doi.org/10.1038/sj.pcan.4500634

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020519994

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12806379


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Surface", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Mutational Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, p53", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kangai-1 Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "School of Medicine, University of New South Wales, Kensington, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1005.4", 
          "name": [
            "Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia", 
            "School of Medicine, University of New South Wales, Kensington, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jackson", 
        "givenName": "P", 
        "id": "sg:person.0755741540.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755741540.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Medicine, University of New South Wales, Kensington, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1005.4", 
          "name": [
            "Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia", 
            "School of Medicine, University of New South Wales, Kensington, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ow", 
        "givenName": "K", 
        "id": "sg:person.0747754107.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747754107.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Medicine, University of New South Wales, Kensington, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1005.4", 
          "name": [
            "Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia", 
            "School of Medicine, University of New South Wales, Kensington, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yardley", 
        "givenName": "G", 
        "id": "sg:person.01001760753.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001760753.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Douglass Hanly Moir Pathology, Sydney, Australia", 
          "id": "http://www.grid.ac/institutes/grid.410690.a", 
          "name": [
            "Douglass Hanly Moir Pathology, Sydney, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Delprado", 
        "givenName": "W", 
        "id": "sg:person.0627313160.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627313160.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Toxicology, University of New South Wales, Kensington, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1005.4", 
          "name": [
            "Department of Clinical Pharmacology and Toxicology, University of New South Wales, Kensington, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quinn", 
        "givenName": "D I", 
        "id": "sg:person.01013134010.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Medicine, University of New South Wales, Kensington, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1005.4", 
          "name": [
            "Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia", 
            "School of Medicine, University of New South Wales, Kensington, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "J-L", 
        "id": "sg:person.01215220717.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215220717.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Medicine, University of New South Wales, Kensington, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1005.4", 
          "name": [
            "Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia", 
            "School of Medicine, University of New South Wales, Kensington, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Russell", 
        "givenName": "P J", 
        "id": "sg:person.015513311052.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015513311052.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.pcan.4500521", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027083139", 
          "https://doi.org/10.1038/sj.pcan.4500521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1203580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053736737", 
          "https://doi.org/10.1038/sj.onc.1203580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026734000", 
          "https://doi.org/10.1038/sj.onc.1201648"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-06-01", 
    "datePublishedReg": "2003-06-01", 
    "description": "Recent data have proposed that transcription of the KAI1 metastasis suppressor gene is directly mediated by p53 and that loss of KAI1 expression in advanced prostate cancer is simply due to loss of p53 function after mutation. To investigate this possibility, we have examined KAI1 mRNA (by in situ hybridisation) and p53 protein expression (by immunohistochemistry) as an indicator of wildtype or mutant p53, in a series of 77 paraffin-embedded prostate tissue samples, including post-mortem normal prostates (2), benign prostatic hyperplasia (10), localised cancer (grades 4\u20136, 25; grades 7\u20139, 21) and prostate-derived bony metastases (19). Overall, we confirmed that expression of KAI1 mRNA decreased from normal tissue, through localised cancer to bony metastases (P=0.055, tending to significance), while levels of p53 staining significantly increased with cancer progression (P=0.046). These were consistent with the possibility that loss of p53 function might be responsible for loss of KAI1 mRNA. However, by close examination of KAI1 and p53 in adjacent tissue sections, we found no correlation between decreased levels of KAI1 mRNA and overexpression of p53 protein (P=0.497). In addition, high levels of KAI1 mRNA could be identified in samples irrespective of p53 staining. Our data suggest that mutation of p53 is independent of the loss of KAI1 mRNA, and do not support a role for p53 in regulating the expression of KAI1.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.pcan.4500634", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1119336", 
        "issn": [
          "1365-7852", 
          "1476-5608"
        ], 
        "name": "Prostate Cancer and Prostatic Diseases", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "bony metastases", 
      "KAI1 mRNA", 
      "p53 staining", 
      "prostate cancer", 
      "advanced prostate cancer", 
      "benign prostatic hyperplasia", 
      "expression of KAI1", 
      "p53 protein expression", 
      "p53 function", 
      "mutation of p53", 
      "prostate tissue samples", 
      "prostatic hyperplasia", 
      "metastasis suppressor gene", 
      "p53 overexpression", 
      "adjacent tissue sections", 
      "normal prostate", 
      "KAI1 expression", 
      "KAI1 metastasis suppressor gene", 
      "cancer", 
      "normal tissues", 
      "metastasis", 
      "cancer progression", 
      "decreased levels", 
      "protein expression", 
      "tissue samples", 
      "p53 protein", 
      "mutant p53", 
      "tissue sections", 
      "p53", 
      "recent data", 
      "suppressor gene", 
      "KAI1", 
      "mRNA", 
      "staining", 
      "expression", 
      "overexpression", 
      "high levels", 
      "hyperplasia", 
      "prostate", 
      "mutations", 
      "levels", 
      "progression", 
      "downregulation", 
      "loss", 
      "tissue", 
      "examination", 
      "wildtype", 
      "function", 
      "samples", 
      "data", 
      "protein", 
      "genes", 
      "role", 
      "correlation", 
      "transcription", 
      "indicators", 
      "possibility", 
      "addition", 
      "close examination", 
      "series", 
      "sections"
    ], 
    "name": "Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression", 
    "pagination": "174-181", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020519994"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.pcan.4500634"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12806379"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.pcan.4500634", 
      "https://app.dimensions.ai/details/publication/pub.1020519994"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_377.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.pcan.4500634"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500634'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500634'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500634'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500634'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      107 URIs      96 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.pcan.4500634 schema:about N04182a4d74234e19aaa3b12f985dc755
2 N0d5aadaa9a55463c8fd749ef72c04e26
3 N148d0c04da07459ea4804d380facad49
4 N1856ede249d14453ba7965e88c372b73
5 N22e604bf097644e4b9a0bb3c755b25b5
6 N68e140b2414344228170ebee00f165a0
7 N6a46c49a83d247aebd160118f358b845
8 N6eaa042e10c349b390222fc3b42d325c
9 N73e37ddd3763443887d3f053654b65d7
10 N860be8fae7b6484aac0ce7727ce46632
11 N892718e657e240c596a9418452c039ea
12 N904ef3263c1a4181b0792d2b1c8be559
13 Na028c35a13a04a399176fcbd5e3c9326
14 Nb90b06922396485f8095c4f8d8865de5
15 Ndfd152747cfe4b268209f9bf06e9b289
16 Ne1e204902fc5408a98c9e51ecd032239
17 Nf08e274c7368444d9145facc175a9d6c
18 Nf382c4f67444472ba6c8b2be15d662b2
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N1f8373606d6b47719735b14bd8168785
22 schema:citation sg:pub.10.1038/sj.onc.1201648
23 sg:pub.10.1038/sj.onc.1203580
24 sg:pub.10.1038/sj.pcan.4500521
25 schema:datePublished 2003-06-01
26 schema:datePublishedReg 2003-06-01
27 schema:description Recent data have proposed that transcription of the KAI1 metastasis suppressor gene is directly mediated by p53 and that loss of KAI1 expression in advanced prostate cancer is simply due to loss of p53 function after mutation. To investigate this possibility, we have examined KAI1 mRNA (by in situ hybridisation) and p53 protein expression (by immunohistochemistry) as an indicator of wildtype or mutant p53, in a series of 77 paraffin-embedded prostate tissue samples, including post-mortem normal prostates (2), benign prostatic hyperplasia (10), localised cancer (grades 4–6, 25; grades 7–9, 21) and prostate-derived bony metastases (19). Overall, we confirmed that expression of KAI1 mRNA decreased from normal tissue, through localised cancer to bony metastases (P=0.055, tending to significance), while levels of p53 staining significantly increased with cancer progression (P=0.046). These were consistent with the possibility that loss of p53 function might be responsible for loss of KAI1 mRNA. However, by close examination of KAI1 and p53 in adjacent tissue sections, we found no correlation between decreased levels of KAI1 mRNA and overexpression of p53 protein (P=0.497). In addition, high levels of KAI1 mRNA could be identified in samples irrespective of p53 staining. Our data suggest that mutation of p53 is independent of the loss of KAI1 mRNA, and do not support a role for p53 in regulating the expression of KAI1.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf N2a45fe4ef0de4f4e83ccdcd268c4bf8e
31 N464ee93742a64c248e5ddc25d16948bd
32 sg:journal.1119336
33 schema:keywords KAI1
34 KAI1 expression
35 KAI1 mRNA
36 KAI1 metastasis suppressor gene
37 addition
38 adjacent tissue sections
39 advanced prostate cancer
40 benign prostatic hyperplasia
41 bony metastases
42 cancer
43 cancer progression
44 close examination
45 correlation
46 data
47 decreased levels
48 downregulation
49 examination
50 expression
51 expression of KAI1
52 function
53 genes
54 high levels
55 hyperplasia
56 indicators
57 levels
58 loss
59 mRNA
60 metastasis
61 metastasis suppressor gene
62 mutant p53
63 mutation of p53
64 mutations
65 normal prostate
66 normal tissues
67 overexpression
68 p53
69 p53 function
70 p53 overexpression
71 p53 protein
72 p53 protein expression
73 p53 staining
74 possibility
75 progression
76 prostate
77 prostate cancer
78 prostate tissue samples
79 prostatic hyperplasia
80 protein
81 protein expression
82 recent data
83 role
84 samples
85 sections
86 series
87 staining
88 suppressor gene
89 tissue
90 tissue samples
91 tissue sections
92 transcription
93 wildtype
94 schema:name Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression
95 schema:pagination 174-181
96 schema:productId N50a296dcc710422c97087cbd01ba27d0
97 N5b553dc0407e483d945ed034cc56b338
98 Nbc942d8de52748758a7682d6750bd3ad
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020519994
100 https://doi.org/10.1038/sj.pcan.4500634
101 schema:sdDatePublished 2022-10-01T06:32
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher N3d1f0bc7246641e49a8135091c42c486
104 schema:url https://doi.org/10.1038/sj.pcan.4500634
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N04182a4d74234e19aaa3b12f985dc755 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Bone Neoplasms
110 rdf:type schema:DefinedTerm
111 N0d5aadaa9a55463c8fd749ef72c04e26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Prostatic Neoplasms
113 rdf:type schema:DefinedTerm
114 N148d0c04da07459ea4804d380facad49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name In Situ Hybridization
116 rdf:type schema:DefinedTerm
117 N1856ede249d14453ba7965e88c372b73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Down-Regulation
119 rdf:type schema:DefinedTerm
120 N1f8373606d6b47719735b14bd8168785 rdf:first sg:person.0755741540.65
121 rdf:rest N3adf7e21e6ca41509275570174ad967b
122 N22e604bf097644e4b9a0bb3c755b25b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Genes, p53
124 rdf:type schema:DefinedTerm
125 N240f919d0d13439880934587d28b025a rdf:first sg:person.01215220717.31
126 rdf:rest N54a86c46eba341f193ebac4b003d2da1
127 N2a45fe4ef0de4f4e83ccdcd268c4bf8e schema:volumeNumber 6
128 rdf:type schema:PublicationVolume
129 N3663d55571714c14a25b20fa5e0ce416 rdf:first sg:person.0627313160.31
130 rdf:rest Ne3ca7c5a54ca46e9976b4474d0dec83d
131 N3adf7e21e6ca41509275570174ad967b rdf:first sg:person.0747754107.10
132 rdf:rest Ncec68ab7c0d246a783e7cb84aaf512a5
133 N3d1f0bc7246641e49a8135091c42c486 schema:name Springer Nature - SN SciGraph project
134 rdf:type schema:Organization
135 N464ee93742a64c248e5ddc25d16948bd schema:issueNumber 2
136 rdf:type schema:PublicationIssue
137 N50a296dcc710422c97087cbd01ba27d0 schema:name pubmed_id
138 schema:value 12806379
139 rdf:type schema:PropertyValue
140 N54a86c46eba341f193ebac4b003d2da1 rdf:first sg:person.015513311052.53
141 rdf:rest rdf:nil
142 N5b553dc0407e483d945ed034cc56b338 schema:name doi
143 schema:value 10.1038/sj.pcan.4500634
144 rdf:type schema:PropertyValue
145 N68e140b2414344228170ebee00f165a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Adult
147 rdf:type schema:DefinedTerm
148 N6a46c49a83d247aebd160118f358b845 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name DNA Mutational Analysis
150 rdf:type schema:DefinedTerm
151 N6eaa042e10c349b390222fc3b42d325c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Male
153 rdf:type schema:DefinedTerm
154 N73e37ddd3763443887d3f053654b65d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Immunohistochemistry
156 rdf:type schema:DefinedTerm
157 N860be8fae7b6484aac0ce7727ce46632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Kangai-1 Protein
159 rdf:type schema:DefinedTerm
160 N892718e657e240c596a9418452c039ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Membrane Glycoproteins
162 rdf:type schema:DefinedTerm
163 N904ef3263c1a4181b0792d2b1c8be559 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Antigens, Surface
165 rdf:type schema:DefinedTerm
166 Na028c35a13a04a399176fcbd5e3c9326 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Proto-Oncogene Proteins
168 rdf:type schema:DefinedTerm
169 Nb90b06922396485f8095c4f8d8865de5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name RNA, Messenger
171 rdf:type schema:DefinedTerm
172 Nbc942d8de52748758a7682d6750bd3ad schema:name dimensions_id
173 schema:value pub.1020519994
174 rdf:type schema:PropertyValue
175 Ncec68ab7c0d246a783e7cb84aaf512a5 rdf:first sg:person.01001760753.78
176 rdf:rest N3663d55571714c14a25b20fa5e0ce416
177 Ndfd152747cfe4b268209f9bf06e9b289 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Antigens, CD
179 rdf:type schema:DefinedTerm
180 Ne1e204902fc5408a98c9e51ecd032239 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Humans
182 rdf:type schema:DefinedTerm
183 Ne3ca7c5a54ca46e9976b4474d0dec83d rdf:first sg:person.01013134010.15
184 rdf:rest N240f919d0d13439880934587d28b025a
185 Nf08e274c7368444d9145facc175a9d6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name DNA, Neoplasm
187 rdf:type schema:DefinedTerm
188 Nf382c4f67444472ba6c8b2be15d662b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Middle Aged
190 rdf:type schema:DefinedTerm
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
195 schema:name Oncology and Carcinogenesis
196 rdf:type schema:DefinedTerm
197 sg:journal.1119336 schema:issn 1365-7852
198 1476-5608
199 schema:name Prostate Cancer and Prostatic Diseases
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01001760753.78 schema:affiliation grid-institutes:grid.1005.4
203 schema:familyName Yardley
204 schema:givenName G
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001760753.78
206 rdf:type schema:Person
207 sg:person.01013134010.15 schema:affiliation grid-institutes:grid.1005.4
208 schema:familyName Quinn
209 schema:givenName D I
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15
211 rdf:type schema:Person
212 sg:person.01215220717.31 schema:affiliation grid-institutes:grid.1005.4
213 schema:familyName Yang
214 schema:givenName J-L
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215220717.31
216 rdf:type schema:Person
217 sg:person.015513311052.53 schema:affiliation grid-institutes:grid.1005.4
218 schema:familyName Russell
219 schema:givenName P J
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015513311052.53
221 rdf:type schema:Person
222 sg:person.0627313160.31 schema:affiliation grid-institutes:grid.410690.a
223 schema:familyName Delprado
224 schema:givenName W
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627313160.31
226 rdf:type schema:Person
227 sg:person.0747754107.10 schema:affiliation grid-institutes:grid.1005.4
228 schema:familyName Ow
229 schema:givenName K
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747754107.10
231 rdf:type schema:Person
232 sg:person.0755741540.65 schema:affiliation grid-institutes:grid.1005.4
233 schema:familyName Jackson
234 schema:givenName P
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755741540.65
236 rdf:type schema:Person
237 sg:pub.10.1038/sj.onc.1201648 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026734000
238 https://doi.org/10.1038/sj.onc.1201648
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/sj.onc.1203580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053736737
241 https://doi.org/10.1038/sj.onc.1203580
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/sj.pcan.4500521 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027083139
244 https://doi.org/10.1038/sj.pcan.4500521
245 rdf:type schema:CreativeWork
246 grid-institutes:grid.1005.4 schema:alternateName Department of Clinical Pharmacology and Toxicology, University of New South Wales, Kensington, NSW, Australia
247 School of Medicine, University of New South Wales, Kensington, NSW, Australia
248 schema:name Department of Clinical Pharmacology and Toxicology, University of New South Wales, Kensington, NSW, Australia
249 Oncology Research Centre, Prince of Wales Hospital, Randwick, NSW, Australia
250 School of Medicine, University of New South Wales, Kensington, NSW, Australia
251 rdf:type schema:Organization
252 grid-institutes:grid.410690.a schema:alternateName Douglass Hanly Moir Pathology, Sydney, Australia
253 schema:name Douglass Hanly Moir Pathology, Sydney, Australia
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...